Publications by authors named "Michal Mazurek"

Claim this Profile
M
Management of device-detected subclinical atrial fibrillation: a European Heart Rhythm Association survey.
Ilaria Meynet, Jarkko Karvonen, Giuseppe Boriani, Diego Penela, Michal Mazurek

Europace· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical atrial flutter ablation: clinical practice on patient selection, mapping, ablation strategies, and procedural endpoints-results from a European Heart Rhythm Association survey.
Giulio Falasconi, Antonio Berruezo, Martina Nesti, Maura Zylla, Mark T Mills, Michal Mazurek

Europace· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulsed field ablation for atrial fibrillation ablation: a European Heart Rhythm Association survey.
Marco Bergonti, Mark T Mills, Laurent Roten, Martin H Ruwald, Andreas Metzner, Michal Mazurek

Europace· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary prevention implantable cardioverter-defibrillator therapy in non-ischaemic heart failure with reduced left ventricular ejection fraction: a European Heart Rhythm Association survey.
Emil Brociek, Jarkko Karvonen, Mark T Mills, Martin H Ruwald, Federico Migliore, Michal Mazurek

Europace· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with a leadless pacemaker versus transvenous pacemaker.
Szymon Warwas, Ewa Jędrzejczyk-Patej, Oskar Kowalski, Adam Sokal, Sławomir Pluta, Michał Mazurek

Kardiol Pol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular access site management during electrophysiology procedures: a European Heart Rhythm Association survey.
Mark T Mills, Dhiraj Gupta, Vishal Luther, Maura M Zylla, Piotr Futyma, Michal Mazurek

Europace· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the wearable cardioverter defibrillator in the initial period of sudden cardiac death risk stratification: results of a European Heart Rhythm Association survey.
Federico Migliore, Laura Perrotta, Mark T Mills, Ante Anic, Arian Sultan, Michał Mazurek

Europace· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echocardiographic imaging in patients with conduction system pacing.
Alexander Suchodolski, Ewa Jędrzejczyk-Patej, Wiktoria Kowalska, Michał Mazurek, Radosław Lenarczyk

Cardiovasc Ultrasound· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of shock therapy on depression development and remote prognosis in cardiac resynchronization therapy recipients.
Tomasz Podolecki, Robert Pudlo, Michał Mazurek, Monika Kozieł-Siołkowska, Joanna Boidol

Cardiol J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes, mortality predictors, and cardiac-device-related infective endocarditis in patients with surgically corrected valvular versus non-valvular heart failure treated with cardiac resynchronization therapy.
Ewa Jędrzejczyk-Patej, Michał Mazurek, Radosław Lenarczyk, Adam Sokal, Agnieszka Kotalczyk

Kardiol Pol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left bundle branch area pacing in children: case series.
Ewa Jędrzejczyk-Patej, Michał Mazurek, Oskar Kowalski, Mariola Szulik, Filip Tyc

Eur Heart J Case Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure.
Ewa Jędrzejczyk-Patej, Michał Mazurek, Monika Lazar, Patrycja Pruszkowska-Skrzep, Adam Sokal

Kardiol Pol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implantation of AV leadless pacemaker - a case report.
Szymon Warwas, Ewa Jędrzejczyk-Patej, Marta Jagosz, Michał Mazurek, Oskar Kowalski

Pol Merkur Lekarski· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with a subcutaneous vs. transvenous implantable cardioverter-defibrillator.
Marta Jagosz, Ewa Jędrzejczyk-Patej, Wiktoria Kowalska, Michał Mazurek, Szymon Warwas

Kardiol Pol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke prevention strategies in high-risk patients with atrial fibrillation.
Agnieszka Kotalczyk, Michał Mazurek, Zbigniew Kalarus, Tatjana S Potpara, Gregory Y H Lip

Nat Rev Cardiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Ewa Jędrzejczyk-Patej, Michał Mazurek, Agnieszka Kotalczyk, Wiktoria Kowalska, Aleksandra Konieczny-Kozielska

Europace· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electro Heart Team: integrating new approaches to atrial fibrillation management. Authors' reply.
Agnieszka Wojdyła-Hordyńska, Jakub Baran, Michał Mazurek, Paweł Derejko

Kardiol Pol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perspective and safety of remote monitoring of implantable cardioverter-defibrillators in the Polish Nationwide Multicenter Registry: the Medtronic CareLink network evaluation.
Aleksander Maciąg, Przemysław Mitkowski, Michał Mazurek, Jarosław Kaźmierczak, Krzysztof Nowak

Kardiol Pol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply.
Jacob Tfelt-Hansen, Jesper Hastrup Svendsen, Zbigniew Kalarus, Davide Capodanno, Gheorghe-Andrei Dan, Michał Mazurek

Europace· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a survey concerning atrial fibrillation ablation strategies in Poland.
Agnieszka Wojdyła-Hordyńska, Jakub Baran, Michał Mazurek, Paweł Derejko

Kardiol Pol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply.
Jacob Tfelt-Hansen, Jesper Hastrup Svendsen, Zbigniew Kalarus, Davide Capodanno, Gheorghe-Andrei Dan, Michał Mazurek

Europace· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply.
Jacob Tfelt-Hansen, Jesper Hastrup Svendsen, Zbigniew Kalarus, Davide Capodanno, Gheorghe-Andrei Dan, Michał Mazurek

Europace· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
Monika Kozieł, Michał Mazurek, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner

J Clin Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful implantation of leadless pacemakers in children: a case series.
Ewa Jędrzejczyk-Patej, Aleksandra Woźniak, Linda Litwin, Alina Skiba-Zdrzałek, Michał Mazurek

Eur Heart J Case Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Michał Mazurek, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner, Jonathan L Halperin

Am Heart J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis